Literature DB >> 12820445

Simultaneous combination of chemotherapy using protracted infusion of low-dose cisplatin and 5-fluorouracil with radiotherapy. Relationship between the size of the irradiation field and hemotoxicity.

Yoshiyuki Itoh1, Nobukazu Huwa.   

Abstract

BACKGROUND: We simultaneously administered continuous intravenous injection of low-dose cisplatin (CDDP) and 5-fluorouracil (5-FU) in combination with radiation to treat patients with esophageal or lung cancer. In this study, we investigated the relationship between the grade of hemotoxicity and the area of the irradiation field in these patients.
MATERIALS AND METHODS: Between March 1993 and December 1998, 21 patients with esophageal cancer and 12 with lung cancer, who had undergone this combined therapy, were analyzed with regards to several factors, including age, radiation dose, the size of the irradiation field and dose of CDDP administered.
RESULTS: The area of the irradiation field was significantly larger in patients with esophageal cancer (p = 0.0079), whilst with regards to hemotoxicity, both the white blood cell count (WBC) and the platelet count were significantly reduced in patients with esophageal cancer (p = 0.0047 and p = 0.0407, respectively).
CONCLUSION: The size of the irradiation field is related to the grade of hemotoxicity when chemo-radiotherapy is simultaneously administered.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820445

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Elective nodal irradiation or involved-field irradiation in definitive chemoradiotherapy for esophageal squamous cell cancer: a retrospective analysis in clinical N0 patients.

Authors:  Y Sun; X L Zhang; Q F Mao; Y H Liu; L Kong; M H Li
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

2.  Retrospective analysis: concurrent chemoradiotherapy using protracted continuous infusion of low-dose cisplatin and 5-fluorouracil for T2N0 glottic cancer.

Authors:  Yoshiyuki Itoh; Nobukazu Fuwa
Journal:  Radiat Med       Date:  2006-05

Review 3.  Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice.

Authors:  Minghuan Li; Xiaoli Zhang; Fen Zhao; Yijun Luo; Li Kong; Jinming Yu
Journal:  Radiat Oncol       Date:  2016-02-05       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.